Kawasumi Laboratories, Incorporated announced consolidated earnings results for the six months ended September 30, 2019. For the period, the company reported net sales of JPY 11,324 million against JPY 11,627 million a year ago. Operating profit was JPY 535 million against JPY 62 million a year ago. Profit was JPY 375 million against loss of JPY 891 million a year ago. Earnings per share were JPY 18.19 against loss per share of JPY 41.75 a year ago.

The company provided consolidated earnings guidance for the year ending March 31, 2020. For the full year, the company expected net sales of JPY 22,200 million, operating profit of JPY 900 million and profit attributable to owners of parent of JPY 600 million or JPY 29.05 per share.

The company announced a dividend of JPY 7.50 per share for the second quarter ended September 30, 2019 against JPY 7.50 per share paid a year ago. Scheduled date to commence dividend payment is December 2, 2019 .

The company provided year end dividend guidance for the year ending March 31, 2020. For the year, the company expects to pay a year end dividend of JPY 7.50 per share against JPY 7.50 per share paid a year ago.